| Title : Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond - Li_2022_Eur.J.Nucl.Med.Mol.Imaging_49_2844 |
| Author(s) : Li M , Younis MH , Zhang Y , Cai W , Lan X |
| Ref : Eur J Nucl Med Mol Imaging , 49 :2844 , 2022 |
| Abstract : |
| PubMedSearch : Li_2022_Eur.J.Nucl.Med.Mol.Imaging_49_2844 |
| PubMedID: 35098327 |
| Title : Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond - Li_2022_Eur.J.Nucl.Med.Mol.Imaging_49_2844 |
| Author(s) : Li M , Younis MH , Zhang Y , Cai W , Lan X |
| Ref : Eur J Nucl Med Mol Imaging , 49 :2844 , 2022 |
| Abstract : |
| PubMedSearch : Li_2022_Eur.J.Nucl.Med.Mol.Imaging_49_2844 |
| PubMedID: 35098327 |
| Title : Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond - Li_2022_Eur.J.Nucl.Med.Mol.Imaging_49_2844 |
| Author(s) : Li M , Younis MH , Zhang Y , Cai W , Lan X |
| Ref : Eur J Nucl Med Mol Imaging , 49 :2844 , 2022 |
| Abstract : |
| PubMedSearch : Li_2022_Eur.J.Nucl.Med.Mol.Imaging_49_2844 |
| PubMedID: 35098327 |